Click to Share

Filter News
Show All Results
News By Country
News By Tag
Diagnostics Remove

February 2020

Public Company News

Business Press Releases

Diagnostics Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Molecular Depot LLC
Molecular Depot LLC now offers an Interference Test Kit containing six endogenous substances to use in assay routine interference testing.
By Molecular Depot LLC
Rheumatoid Factor (RF) interference is a major issue when testing the performance of immunoassays.
By Nuevozen
Nuevozen a healthcare Artificial Intelligence company developing patient risk assessment and diagnostic solutions for cancer and other serious diseases, is pleased to announce the addition of Dr.
By 83bar, LLC
- Market research insights from recent patient activation tests using the 83bar integrated digital health platform - Highlights from eight important medical categories, including depression, migraine, and NASH - Implications of findings for pharma...
By Nova Biomedical
Nova Biomedical is pleased to announce the next addition to the Stat Profile product line with the Stat Profile Prime ES Comp Plus.
By 83bar, LLC
- Patient Activation: The 4 Steps to Move Health Care Consumers from Awareness to Action - Now in paperback and Kindle - Learn a different mindset and fully-integrated system to transition people from being passive patients to active consumers of health..
By UCLA Engineering ITA
Many biosensing applications rely on characterization of specific analytes such as proteins, viruses, bacteria, among many other targets, which can be accomplished by using micro- or nano-scale particles.
By Abingdon Health
Abingdon Health ("Abingdon") is pleased to announce it has been awarded a grant by Innovate UK to develop an on-farm multiplex rapid test for mastitis in cattle.
By Nova Biomedical
Only glucose meter FDA cleared for use with critically ill patients
By UCLA Ozcan Research Group
Leti, a research institute at CEA Tech, and Cellmic LLC, a company dedicated to improving patient healthcare with smartphones and biophotonics, today announced that they joined forces to accelerate the market adoption of lens-free imaging and sensing...
By SMi Group
SMi proudly presents its 5th annual conference on Molecular Diagnostics, taking place at the Holiday Inn Kensington Forum, London, UK on 9th and 10th July 2018, with a half-day post-conference workshops on 11th July 2018.

Page updated every 10 minutes

Like PRLog?
Click to Share